Autopsy report · NCT04705337

Levosimendan In Ambulatory Heart Failure Patients

“The level of recruitment, 62 participants enrolled, does not allow for achieving the protocol-defined target of 350 participants by the end of the recruitment period.”

The sponsor’s own words in the registry.

Life of this trial

• Registered 11 months before it started.
• Ran for about 2 years 8 months before it stopped.
• 70 participants enrolled.
• No results are posted on the registry.

Vital statistics

Status

Terminated

Phase

Phase 4

Sponsor

Medical University of Bialystok

Sponsor type

University, hospital or other

Conditions

Heart Failure New York Heart Association Class III; Heart Failure New York Heart Association Class IV; Heart Failure, Systolic; Heart Failure With Reduced Ejection Fraction

Interventions

Levosimendan; Placebo

Participants

70

Sites

14

Countries

Poland

Trials that died the same way

• Ovarian Cancer Treatment With a Liposome Formulated mRNA Vaccine in Combination With (Neo-)Adjuvant Chemotherapy
  “Despite the extension of the original recruitment period, the target number of evaluable patients defined in the study protocol could not be reached and recruitment for the trial was stopped at that point of time.” (67% match in meaning)
• Efficacy of Rituximab in Acute Cellular Rejection in Renal Transplant Patients
  “The planned recruitment number of 180 Patient could not been achieved.” (65% match in meaning)
• Contraception Navigator Program
  “Target recruitment was not achieved prior to funding end.” (65% match in meaning)
• Efficacy of Probaclac in Irritable Bowel Syndrome in Children Aged 8 to 18 Years
  “Recruitment impossible” (64% match in meaning)
• Pharmacokinetics of Adalimumab With Methotrexate for Treatment of Patients With Ulcerative Colitis (UC)
  “Unable to achieve recruitment target.” (64% match in meaning)

Look deeper

• The official registry record (the source of truth)
• Record history: every change the sponsor made
• Open it in the database

Everything here comes from the current ClinicalTrials.gov record. The timeline uses the record’s dates; dates marked planned are the sponsor’s plans. The cause of death is an automatic, unverified label. This is research information, not medical advice.